Ramsay Should Outperform From Current Levels

Shares of RHC are down about 20% year to date.

Changes in government funding and regulations have been a headwind for the private health sector, in general, and on RHC, specifically.

You're not a member!  Trial today!

However, recent industry research is estimating RHC EPS growth to reach 8% for FY 18 and then rise to 10% for FY 19.

At $58.20, the stock is trading at 18.7 X 12 month forward EPS.

We see scope for the share price to reach $74.50 over a 12-month time horizon.

Ramsay Health Care

Investor Signals Pty Ltd ABN 44 143 555 453 is a Corporate Authorised Representative CAR No. 439411 of Advisor Plus Pty Ltd AFSL 474520
© 2020 Investor Signals